Tumor Mutational Burden: A Continually Evolving Biomarker for Immunotherapy
MarketScreener,
Dan Brudzewsky, PhD Senior Field Applications Scientist - UK
Dan Brudzewsky, PhD Senior Field Applications Scientist - UK
Guardant Health's NGS-based liquid biopsy test can identify microsatellite instability in cancer patients, offering a less…
The genome-wide intensity of microsatellite instability (MSI) and resulting mutational load, particularly insertion-deletion…
Image credit: Andrew H. Lee Checkpoint inhibitor drugs that stimulate the immune system have become a growing success story in…